LAPOINTE ANTHONY GREGG
Insider CIK 1331860 · RIGL Director · RPTP Director · CTYX Director · CATB Director · SNGX Director · IMUC Director · SCLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 192 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 121 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 63 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 128 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 74 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | D To issuer deriv | 2026-10-12 | 2026-10-13 | 54 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2026-09-17 | 2026-09-18 | 78,947 | — | $0 | 78,947 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2026-09-17 | 2026-09-18 | 78,947 | — | $0 | 78,947 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2026-05-15 | 2026-05-19 | 5,750 | — | $0 | 18,250 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2025-06-20 | 2025-06-20 | 17,647 | — | $0 | 17,647 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2025-05-23 | 2025-05-28 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2025-05-23 | 2025-05-28 | 2,500 | — | $0 | 12,500 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2024-12-12 | 2024-12-13 | 8,646 | — | $0 | 8,646 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2024-05-25 | 2024-05-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2024-05-25 | 2024-05-29 | 25,000 | — | $0 | 100,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2023-12-15 | 2023-12-15 | 38,136 | — | $0 | 38,136 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2023-05-26 | 2023-07-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2023-05-26 | 2023-07-12 | 25,000 | — | $0 | 75,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2022-11-17 | 2022-11-21 | 46,154 | — | $0 | 129,747 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2022-05-20 | 2022-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2022-05-20 | 2022-05-23 | 25,000 | — | $0 | 50,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2021-09-23 | 2021-09-24 | 29,126 | — | $0 | 29,126 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-06-02 | 2021-06-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2021-05-19 | 2021-05-21 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award | 2021-05-19 | 2021-05-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2020-09-16 | 2020-09-18 | 15,228 | — | $0 | 15,228 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2020-06-11 | 2020-06-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2020-05-15 | 2020-05-15 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2019-09-06 | 2019-09-10 | 30,928 | — | $0 | 30,928 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2019-05-23 | 2019-05-24 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-02-13 | 2019-02-15 | 12,200 | — | $0 | 12,200 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-01-03 | 2019-01-04 | 2,800 | — | $0 | 2,800 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-01-03 | 2019-01-04 | 2,800 | — | $0 | 2,800 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2018-09-27 | 2018-09-28 | 17,964 | — | $0 | 17,964 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2018-05-17 | 2018-05-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2017-10-31 | 2017-11-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $5.14 | $154.2K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $6.08 | $182.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $6.05 | $181.5K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $4.40 | $132.0K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 50,000 | $9.94 | $497.0K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 5,000 | $8.95 | $44.8K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $8.17 | $245.1K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $2.03 | $60.9K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $0.28 | $8.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2017-06-08 | 2017-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2017-06-08 | 2017-06-12 | 13,100 | — | $0 | 13,100 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | A Award deriv | 2017-05-22 | 2017-05-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer deriv | 2016-10-25 | 2016-10-26 | 7,915 | — | $0 | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | D To issuer | 2016-10-25 | 2016-10-26 | 8,330 | $9.00 | $75.0K | 0 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | U Tender | 2016-10-24 | 2016-10-26 | 2,092 | $9.00 | $18.8K | 8,330 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2016-06-23 | 2016-06-27 | 8,330 | — | $0 | 10,422 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2016-06-17 | 2016-06-21 | 156,750 | — | $0 | 156,750 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2016-06-16 | 2016-06-20 | 40,541 | — | $0 | 40,541 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-06-09 | 2016-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2016-04-15 | 2016-04-19 | 7,915 | — | $0 | 7,915 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award | 2016-04-15 | 2016-04-19 | 2,092 | — | $0 | 2,092 | SEC↗ |
| IMUC ImmunoCellular Therapeutic | A Award deriv | 2015-09-18 | 2015-09-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise deriv | 2015-08-31 | 2015-08-31 | 25,000 | — | $0 | 0 | SEC↗ |
| SNGX SOLIGENIX, INC. | M Exercise | 2015-08-31 | 2015-08-31 | 25,000 | $0.30 | $7.5K | 73,781 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 19,868 | — | $0 | 19,868 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2015-06-11 | 2015-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2015-01-15 | 2015-01-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2014-06-19 | 2014-06-20 | 13,669 | — | $0 | 13,669 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2014-06-12 | 2014-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2013-09-27 | 2013-10-01 | 13,275 | — | $0 | 13,275 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2013-06-27 | 2013-06-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SNGX SOLIGENIX, INC. | A Award deriv | 2012-06-21 | 2012-07-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2012-06-07 | 2012-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |